GreenLight Biosciences Holdings, PBC Warrant
GRNAW
GRNAW was delisted on the 21st of July, 2023.
19 hedge funds and large institutions have $7.77M invested in GreenLight Biosciences Holdings, PBC Warrant in 2022 Q3 according to their latest regulatory filings, with funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 2 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
14% more capital invested
Capital invested by funds: $6.83M → $7.77M (+$936K)
10% less funds holding
Funds holding: 21 → 19 (-2)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LP
LMR Partners
London,
United Kingdom
|
+$96.9K |
| 2 |
Walleye Capital
New York
|
+$5.32K |
| 3 |
Walleye Trading
New York
|
+$3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Aristeia Capital
Greenwich,
Connecticut
|
-$11K |
| 2 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$2.42K |
| 3 |
Rockefeller Capital Management
New York
|
-$349 |
GRNAW Hedge Fund Activity: Q3 2022 in Review
19 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in GreenLight Biosciences Holdings, PBC Warrant (GRNAW) for Q3 2022, worth a combined $7.77M — up 14% from $6.83M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of GRNAW and 0 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 3 added.
The largest buyer was LMR Partners, adding an estimated $96.9K. The largest seller was Aristeia Capital, exiting entirely with an estimated $11K sold.
- 19 institutional investors held GreenLight Biosciences Holdings, PBC Warrant (GRNAW) as of Q3 2022, down from 21 in Q2 2022.
- Funds reported $7.77M of GreenLight Biosciences Holdings, PBC Warrant stock for Q3 2022, up 14% quarter-over-quarter.
- 0 funds opened new GreenLight Biosciences Holdings, PBC Warrant positions in Q3 2022 and 2 closed out, a net change of -2 holders.
- The largest GreenLight Biosciences Holdings, PBC Warrant buyer in Q3 2022 was LMR Partners, an estimated $96.9K added.
- The largest GreenLight Biosciences Holdings, PBC Warrant seller in Q3 2022 was Aristeia Capital, an estimated $11K sold.
Based on aggregated 13F filings for Q3 2022.